KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 61 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,420,000 | +36.6% | 500 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $4,700,000 | -3.4% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $4,865,000 | +45.0% | 500 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $3,355,000 | -24.8% | 500 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $4,460,000 | +68.3% | 500 | +150.0% | 0.00% | +50.0% |
| Q4 2015 | $2,650,000 | -2.6% | 200 | +100.0% | 0.00% | 0.0% |
| Q2 2015 | $2,721,000 | -11.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $3,061,000 | -18.2% | 100 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $3,743,000 | +22.3% | 100 | 0.0% | 0.00% | +50.0% |
| Q1 2014 | $3,061,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |